Astonea Labs
Astonea Labs Share Price Chart
Astonea Labs last traded at ₹324.00 (2026-10-13). Over the past month the stock moved +12.1%, three months the stock moved +41.5%, year the stock moved +102.6%. Its closing range over 52 weeks is ₹137.05 – ₹354.50, with the latest close 8.6% below the high.
Closing prices up to 2026-10-13.
About Astonea Labs
Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies[1]
Business Overview[1] Astonea Labs is a healthcare and pharmaceutical company with capabilities across pharmaceutical manufacturing, contract development and manufacturing, and cosmetic and personal care manufacturing. Its operations are supported by R&D capabilities, scientific expertise, manufacturing infrastructure and quality systems, serving both domestic and international markets.
Fundamentals
Quarterly Results
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 81.00 | 8.00 | 10.00 | 3.00 | 2.95 |
| Sep 2025 | 66.00 | 5.00 | 8.00 | 1.00 | 1.35 |
| Sep 2024 | 47.00 | 7.00 | 14.00 | 2.00 | 2.76 |
Annual Financials
In the latest year (Mar 2026), Astonea Labs reported sales of ₹148.00 crore (+51.8%) and net profit of ₹5.00 crore (-6.5%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 148.00 | 13.00 | 9.00 | 5.00 | 4.30 |
| Mar 2025 | 97.52 | 15.12 | 15.50 | 5.35 | 6.93 |
| Mar 2024 | 80.16 | 11.95 | 14.91 | 3.81 | 5.01 |
| Mar 2023 | 66.89 | 7.14 | 10.67 | 0.67 | 1.68 |
| Mar 2022 | 30.04 | 5.83 | 19.41 | 0.25 | 0.62 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | +122.7% | +19.8% | +21.7% | +51.8% |
| Operating profit growth | +22.5% | +67.4% | +26.5% | -14.0% |
| Net profit growth | +168.0% | +468.7% | +40.4% | -6.5% |
| EPS growth | +171.0% | +198.2% | +38.3% | -38.0% |
| OPM % | 10.7% | 14.9% | 15.5% | 9.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Astonea Labs.
Get Free AI Stock Analysis FREE →Latest News
-
Astonea Labs receives Yemen SBDMA certificate for facility inspection - scanx.trade
-
Astonea Labs FY26 net profit falls 15.6% as revenue rises 51.3% - scanx.trade
-
Astonea Labs re-appoints Rajan Talwar as Tax Auditor for FY27 - scanx.trade
-
Astonea Labs re-appoints Rajan Talwar as Tax Auditor for FY27 - scanx.trade
-
Astonea Labs re-appoints Rajan Talwar as Tax Auditor for FY27 - scanx.trade
Frequently Asked Questions
What is Astonea Labs's current stock price?
Astonea Labs shares were last quoted at ₹324.00 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Astonea Labs?
Astonea Labs has a price-to-earnings (P/E) ratio of 77.22 and a price-to-book (P/B) ratio of 6.11. The industry P/E is 53.45.
What is the 52-week high and low of Astonea Labs?
The 52-week high of Astonea Labs is ₹369.00 and the 52-week low is ₹118.00.
What is the market cap of Astonea Labs?
The market capitalisation of Astonea Labs is about ₹349.02 crore.
Is Astonea Labs a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Astonea Labs has a 3-year ROE of 22.00%, 3-year profit growth of 97.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Astonea Labs?
Promoters hold about 72.30% of Astonea Labs.
Which sector does Astonea Labs belong to?
Astonea Labs belongs to the Pharmaceuticals & Drugs sector.